Gregory Kline, PhD, JD, is Senior Director, IP Counsel for Thermo Fisher Scientific’s Pharma Services Group, where he leads intellectual property strategy for a multibillion-dollar biologics manufacturing and development organization. With more than 17 years of experience in biotechnology and pharmaceutical innovation, he advises senior leadership on intellectual property, portfolio strategy, and risk management in regulated global manufacturing operations.